Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

Clindamycin may be active against methicillin-resistant Staphylococcus aureus, a common pathogen causing sepsis in infants, but optimal dosing in this population is unknown. We performed a multicenter, prospective pharmacokinetic (PK) and safety study of clindamycin in infants. We analyzed the data...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Gonzalez, Daniel, Delmore, Paula, Bloom, Barry T., Cotten, C. Michael, Poindexter, Brenda B., McGowan, Elisabeth, Shattuck, Karen, Bradford, Kathleen K., Smith, P. Brian, Cohen-Wolkowiez, Michael, Morris, Maurine, Yin, Wanrong, Benjamin, Daniel K., Laughon, Matthew M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2016
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862454/
https://ncbi.nlm.nih.gov/pubmed/26926644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03086-15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares